Flexpoint Ford has exited ArtesRx in a sale to Linden Capital Partners for undisclosed terms. Artes Rx, a behavioral health pharmacy platform, grew from three pharmacies in one state to 16 pharmacies across 15 states under Flexpoint's ownership. The company was co-founded in 2023 by Flexpoint and Dom Meffe, then a senior advisor to the firm.

During Flexpoint's ownership, the firm worked with management to build out Artes Rx's executive leadership team, strengthen its sales infrastructure and establish an in-house M&A engine to pursue add-on acquisitions. Artes Rx serves individuals who depend on complex medication regimens, including patients with serious mental illness, substance use disorders, and intellectual and developmental disabilities, operating pharmacies under local banners with established community and provider relationships. Michael Fazekas, managing director at Flexpoint, said the vision for building a new type of pharmacy platform and a care model prioritizing complex patients had been key drivers of the company's success.

Houlihan Lokey served as financial advisor to Artes Rx on the transaction.